Cystatin C in HIV-infected patients: promising but not yet ready for prime time
Insights
Cystatin C shows promise for monitoring kidney function in HIV patients, but more research is needed. Current data is insufficient to recommend cystatin C for estimating glomerular filtration rate (GFR) in this population.
Area of Science:
- Nephrology
- Infectious Diseases
- Biomarker Discovery
Background:
- Highly active antiretroviral therapy (HAART) has increased the prevalence of chronic kidney disease (CKD) in HIV-infected individuals.
- Serum creatinine is limited for assessing kidney function in this population.
- Cystatin C is a potential biomarker for glomerular filtration rate (GFR) and drug-induced kidney injury in HIV patients.
Discussion:
- Serum cystatin C levels are influenced by factors beyond GFR, including C-reactive protein, HIV viral load, and CD4+ cell count.
- These non-GFR determinants complicate the interpretation of cystatin C as a sole marker of renal function.
- Existing studies on cystatin C accuracy for GFR estimation in HIV are limited by methodology and sample size.
Key Insights:
- Current evidence is insufficient to support the routine use of cystatin C or cystatin C-based equations for GFR estimation in HIV-infected individuals.
- Further rigorous research is required to establish the clinical utility of cystatin C in this specific patient group.
- The role of cystatin C in predicting patient outcomes, especially cardiovascular events, warrants investigation.
Outlook:
- Future studies should focus on validating cystatin C-based GFR estimation equations in diverse HIV populations.
- Investigating cystatin C as a prognostic marker for cardiovascular morbidity and mortality in HIV is crucial.
- Exploring the combined use of cystatin C with other biomarkers may enhance kidney disease monitoring in HIV.
Abstract:
With the development of highly active antiretroviral therapy, chronic kidney disease has become a prominent cause of morbidity in individuals infected by HIV. Because serum creatinine has significant limitations in this specific population, cystatin C is emerging as a promising biomarker for both the evaluation of glomerular filtration rate (GFR) and the detection of drug-induced kidney injury. Along with renal function, serum cystatin C concentration is associated with several biological parameters such as C-reactive protein, HIV viral load and CD4+ cells count. All these determinants of cystatin C are, however, more or less independent of GFR. Studies evaluating the accuracy of cystatin C for estimating GFR in the setting of HIV infection are scarce and methodology is often questionable (lack of reference method or inadequate statistical analyses). Thus far, data are insufficient to encourage the use of cystatin C or cystatin C-based equations to estimate GFR in the HIV-infected population. Further research is needed to explore the clinical utility of cystatin C in this setting. Beyond the use of cystatin C as a GFR marker, future studies will have to evaluate its role as a predictor of patient outcome, particularly in regard to cardiovascular morbi-mortality.
More Related Videos
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
01:24Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...